David Wayne Magnusson David Wayne Magnusson, 72, passed away peacefully on Dec. 13, 2024 due to complications of Parkinson’s disease. He was diagnosed ...
Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase II for Amyotrophic Lateral Sclerosis.
After reinvigorating a decades-old schizophrenia drug in an innovative long-acting treatment option, Teva is looking to ...
The book, a dual biography of the two women’s enmeshed personal lives and careers, drops the veil on the prolific L.A.
Beta-blockers are linked to delayed motor decline in premanifest Huntington disease and reduced symptom progression in early ...